(1 - 23 von 32
)
MiroBio Continues Expansion of Executive Leadership Team ...
www.investegate.co.uk
— Carolin Barth, M.D., CEO of MiroBio. “MiroBio's inhibitory receptor agonist approach represents a promising new mode of action for treating ... › gnw
DR. CAROLIN BARTH JOINS MIROBIO AS CEO TO LEAD …
oxfordsp.com
TīmeklisOxford, U.K. – 21 September – MiroBio, a biotechnology company advancing a new class of precision therapies designed to address the immune imbalance that drives autoimmune disease, today announced the appointment of Carolin Barth, M.D., as chief executive officer. Dr.
Dr. Carolin Barth Joins MiroBio as CEO to Lead Precision Immunology...
www.dailyadvent.com
Former Novartis executive to lead emerging biotech with a novel precision approach to autoimmune disease, supported by recent senior appointments
MiroBio is...
Dr. Carolin Barth Joins MiroBio as CEO to Lead Precisionwww.globenewswire.com › › Dr-Caroli...
www.globenewswire.com
Dr. Carolin Barth Joins MiroBio as CEO to Lead Precision Immunology Company Focused on Checkpoint Agonist Antibodies. September 21, :30 ET | Source: ...
sortiert nach Relevanz / Datum